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Abstract 
Depression in schizophrenia represents a challenge from a diagnostic, psychopathological and therapeutic 
perspective. The objective of this study is to test the hypothesis that resilience and self-stigma affect 
depression severity and to evaluate the strength of their relations in 921 patients with schizophrenia. A 
structural equation model was tested where depression is hypothesized as affected by resilience, internalized 
stigma, gender and negative symptoms, with the latter two variables used as exogenous covariates and the 
former two as mediators. The analysis reveals that low resilience, high negative symptoms, female gender 
were directly associated with depression severity, and internalized stigma acted only as a mediator between 
avolition and resilience, with similar magnitude. The cross-sectional study design and the variable selection 
limit the generalizability of the study results. The model supports a complex interaction between personal 
resources and negative symptoms in predicting depression in schizophrenia. The clinical implication of these 
findings is that personal resources could be a significant target of psychosocial treatments. 
 
1. Introduction 
Depression is a frequently occurring symptom in schizophrenia, although often under-recognized and under-
treated (Mulholland and Cooper, 2000). The estimated prevalence ranges from 7% to 80% (Rabany et al., 
2013), with a modal rate of 25%, suggesting a strong variation that goes beyond sample heterogeneity. 
Depressive symptoms are associated with greater impairments in well-being and global functioning, as well 
as enhanced risk of suicide (Schennach-Wolff et al., 2011), making depression in schizophrenia a key area of 
assessment and intervention. Although this issue has been explored from historical, pathophysiological, 
diagnostic and therapeutic perspectives (Chiappelli et al., 2014a, Chemerinski et al., 2008, Häfner, 2005, Siris, 
2000), several inconsistencies in depression assessment in schizophrenia emerged, especially due to a 
possible overlap with other psychopathological dimensions, including negative symptoms. Indeed, several 
studies have analyzed the association between depression and other symptoms in schizophrenic patients, 
with mixed results (Lako et al., 2012, Rabany et al., 2011, Rocca et al., 2005). The issue of the overlap between 
negative and depressive symptoms has been debated in the literature, with the prevailing view of a moderate 
association, while a low association with positive symptoms has been reported (Majadas et al., 2012). 
The overlap between negative and depressive symptoms may be in part due to the psychometric properties 
of the rating scales used rather than to the characteristics of the illness itself (Rocca et al., 2005), although 
an overlap between the two constructs cannot be ruled out (Chiappelli et al., 2014b, Winograd-Gurvich et 
al., 2006). The use of new instruments with good psychometric properties to assess negative symptoms 
(Carpenter et al., 2016; Daniel et al., 2013; Kirkpatrick et al., 2011) may help to clarify the issue. 
A different perspective has been advocated by Liddle and Barnes, 1988, Liddle et al., 1993, who suggested 
that depression could be due to the experience of psychological deficits in schizophrenia. Subjective 
experience of deficits could represent an indication of vulnerability to depression due to psychological or 
neural mechanisms. Within this perspective two main aspects as internalized stigma and resilience could 
have a role in shaping depression. 
Internalized stigma, also referred to as self-stigma, is characterized by a subjective perception of devaluation, 
marginalization, secrecy, shame, and withdrawal (Boyd et al., 2014). People with a severe mental illness, such 
as schizophrenia, anticipate social rejection and consider themselves as devalued members of society 
(Corrigan et al., 2005). They may internalize negative stereotypes about mental illness and respond by self-
stigma (Mittal et al., 2012). In accordance with the current literature, both stigma and lack of empowerment 
may lead to depression (Lysaker et al., 2013, Sibitz et al., 2011). 
Resilience is a construct encompassing several aspects of personal resources. It is usually defined as a 
dynamic process of adaptation to challenging life conditions that could be protective against mental 
disorders (Kim-Cohen, 2007, Rutter, 2006). In patients with schizophrenia, a correlation between resilience 
and psychosocial functioning has been reported (Kim et al., 2013, Torgalsboen, 2012) so that this issue 
deserves further investigations. 
The aim of the present study is to test the hypothesis that resilience and self-stigma affect depression severity 
in opposite directions: self-stigma worsening and resilience improving. This hypothesis has been verified 
using a structural equation model (SEM), which allows to evaluate complex paths linking covariates to an 
outcome. Using this approach, we designed a model in which resilience and stigma act as mediators and 
gender and negative symptoms are exogenous covariates. 
 
2. Materials and method 
2.1. Participants 
Data for this study were collected from the Italian Network for Research on Psychoses study (NIRP). 
A detailed description of the study can be found elsewhere (Galderisi et al., 2014). In the NIRP study, 
participants were recruited among patients living in the community and consecutively seen at the 
outpatient units of 26 Italian university psychiatric clinics and/or mental health departments. 
Inclusion criteria were a diagnosis of schizophrenia according to DSM-IV, confirmed with the 
Structured Clinical Interview for DSM-IV - Patient version (SCID-I-P), and an age between 18 and 66 
years. Exclusion criteria were: a history of head trauma with loss of consciousness; a history of 
moderate to severe mental retardation or neurological diseases; a history of alcohol and/or 
substance abuse in the last six months; current pregnancy or lactation; inability to provide an 
informed consent; treatment modifications and/or hospitalization due to symptom exacerbation in 
the last three months. All patients signed a written informed consent to participate after receiving 
a comprehensive explanation of the study procedures and goals. Approval of the study protocol was 
obtained from the Local Ethics Committees of each participating center. 
2.2. Procedures 
Recruitment took place from March 2012 to September 2013. A clinical form was filled in with data 
on age of disease onset, course of the disease and treatments, using all available sources of 
information (patient, family, medical records and mental health workers). 
 
2.3. Study variables 
2.3.1. Dependent variable 
Depressive symptoms were evaluated using the Calgary Depression Scale for Schizophrenia (CDSS), 
a rating scale designed to assess the level of depression in people with schizophrenia (Addington et 
al., 1992, Addington et al., 1994). Higher scores represent higher levels of depression. The CDSS 
includes nine items (depression, hopelessness, self-depreciation, guilty ideas of reference, 
pathological guilt, morning depression, early wakening, suicide, observed depression), each rated 
from 0 (absent) to 3 (severe). Ratings > 6 on the total score indicate clinically significant depression 
(Rybakowski et al., 2012). The Italian translation of the CDSS is available on the official website 
(http://www.ucalgary.ca/cdss/). 
2.3.2. Independent variables 
Avolition and expressive deficit were assessed using the Brief Negative Symptom Scale (BNSS) which 
includes 13 items, rated from 0 (normal) to 6 (most impaired), and five negative symptoms domains: 
anhedonia, asociality, avolition, blunted affect and alogia. In line with previous research, domains 
evaluated by the scale loaded on two factors: “avolition”, consisting of anhedonia, asociality and 
avolition, and “poor emotional expression”, including blunted affect and alogia (Kirkpatrick et al., 
2011, Mucci et al., 2015, Strauss and Gold, 2016). 
Resilience was assessed using the Resilience Scale for Adults (RSA) (Friborg et al., 2005). This is a 
self-administered instrument including 33 items that examine intra- and inter-personal protective 
factors thought to facilitate adaptation when facing psychosocial adversity. Items are organized into 
six factors: perception of self, planned future, structured style, social competence, family cohesion, 
and social resources. In this study we used ‘personal strength’ as a factor containing perception of 
self and planned future (Friborg et al., 2005). ‘Personal strength’ measures the level of self-esteem, 
self-efficacy, self-liking, hope, determination and a realistic orientation to life. ‘Social competence’ 
measures extraversion, social adeptness, cheerful mood, an ability to initiate activities, good 
communication skills and flexibility in social matters.’Family cohesion’ measures shared values, 
ability to enjoy family, cohesion, shared optimistic view of future, loyalty, mutual appreciation. 
‘Structured style’ measures goal oriented planning ability. ‘Social resources’ measures social 
support, presence of important persons outside family and feeling of cohesion (Capanna et al., 2015; 
Friborg et al., 2005). 
The experience of stigma and internalized self-rejection was evaluated using the Internalized Stigma 
of Mental Illness (ISMI) (Ritsher et al., 2003; for Italian version see Brohan et al. (2010)). This includes 
29 items and 5 subscales for self-assessment of subjective experience of stigma. Each item is rated 
on a 4-level Likert scale, where higher scores indicate greater levels of internalized stigma (Ritsher 
and Phelan, 2004). 
 
2.4. Statistical analysis 
A SEM model was used to analyze the relationship of depression with gender, avolition, poor 
emotional expressivity, stigma and resilience based on an a priori theoretical model. Gender, 
avolition and poor emotional expressivity were used as exogenous variables, and stigma and 
resilience as mediators. A latent variable for resilience was used, identified by the five items of 
structured style, social competence, family cohesion, social resources and personal strength. The 
CDSS variable was transformed in its square root in order to normalize its distribution. All possible 
paths connecting these variables were traced, and those non-significant (p > 0.05) were removed 
from the model. Standardized path coefficients were obtained, in order to compare paths pointing 
to the same dependent variable. Correlations between pairs of items of resilience were added when 
useful to improve the model fit. The goodness of fit of the final model was assessed using RMSEA, 
CFI and TLI statistic, with RMSEA < 0.080 (Browne and Cudeck, 1993), CFI > 0.900 and TLI > 0.900 
(Hu and Bentler, 1999) denoting good or acceptable fit. 
Stata 13.1 was used for descriptive analyses and Mplus 7.4 for the SEM analysis. 
 
3. Results 
Out of 1691 screened patients, 1180 were eligible for the NIRP study; of these, 202 refused to 
participate, 57 failed to complete the assessments and 921 were included. In accordance with the 
study protocol, clinical and demographic data were not required to patients who refused to 
participate and were not retained for those who dropped out the procedures. 
Table 1 shows that the study population consists mainly of males (69.6%), had a mean age of 40.2 
years and received the first treatment of psychosis at 24.0 years. Almost one-third (29.2%) was 
working at the time of the interview and more than two thirds (68.5%) received atypical 
antipsychotic treatment. 
Table 1. Characteristics of the study population. 
 Twenty-eight percent of the clinical sample reported clinical depression according to CDSS cut-off 
point of > 6. 
Correlations among depression and the variables selected for the SEM model were over 0.20, except 
for three items related to the latent construct of resilience (Table 2). 
Table 2. Correlation matrix of the variables included in the SEM modela 
 
In the SEM model shown in Fig. 1 higher avolition, lower resilience, higher stigma and female gender 
were associated with higher levels of depression. Gender, avolition and resilience were directly 
related to depression, while stigma connected to depression by the mediation of resilience. 
Avolition was also indirectly related with depression through stigma and resilience. Poor emotional 
expressivity was removed from the model because it was unrelated to all the other variables. As 
shown in Table 3, resilience had the strongest direct effect on CDSS (b = −0.301, p < 0.001), but 
overall the covariate most associated with depression through direct and indirect pathways was 
avolition (total b = 0.336, p < 0.001, b = 0.246 indirect effect, b = 0.090 direct effect). The model 
explained 20.1% of the variance of CDSS and had a good fit to the data (RMSEA = 0.046, CFI = 0.978, 
TLI = 0.965). 
Fig. 1. Diagram of the final SEM. Legend: straight lines indicate direct effects; curved lines indicate 
correlations; short lines pointing to the dependent variables report explained variance. 
 
 
Table 3. Standardized effects to depression (CDSS) resulting from the SEM model. 
 
4. Discussion 
With the present study we sought to explore the association between personal resources and 
depression in patients with schizophrenia. To the best of our knowledge, this is the first single study 
addressing this issue using a SEM model on such a large cohort. Moreover, this is the first study that 
specifically investigates the relationships between depression and negative symptoms in 
schizophrenia using newly developed negative symptom scales such as the BNSS. 
In line with previous findings, 28% of clinical sample reported clinical depression according to CDSS 
cut-off point of > 6 (Dan et al., 2011, Rybakowski et al., 2012). From a psychopathological 
perspective, we found that both personal resources and negative symptoms concurred to 
depression. Interestingly, we found that only BNSS pleasure and motivation items (i.e. BNSS 
avolition) showed a significant association with depression, while the emotional expressivity factor 
did not. In so far as anhedonia represents a core symptom of major depression (Fletcher et al., 
2015), this is not surprising. On the other hand, the lack of association of depression severity with 
emotional expressivity further supports the separation of the two BNSS factors (Strauss and Gold, 
2016). 
Inconsistencies in the correlations between depression and negative symptoms reported in the 
literature may be due to differences in the instruments used, as well as in the patients selection 
criteria. For example, Rabany et al. (2011) reported a low negative correlation between the Scale 
for Assessment of Negative Symptoms (SANS) and CDSS, but their sample was made up of 
schizophrenia patients with predominantly negative symptoms. In our model avolition has the 
highest total effect on depression while resilience shows the highest direct effect. Treatments aimed 
to improve avolition could ha a positive impact on depression directly but also improving resilience. 
In our model, low resilience was associated with higher levels of depression. Furthermore, higher 
resilience coupled with lower avolition indicate protection towards depression, balancing the 
subjective experiences of psychological deficits reported by Liddle and Barnes, 1988, Liddle et al., 
1993. It could be argued that what we called ‘personal resources’ could simply be the other face of 
the self-perceived psychological deficit. Nevertheless, the issue of ‘positive’ resources opens new 
opportunities to investigate outcome variability in schizophrenia. 
High internalized stigma was associated with higher depression, consistent with other studies 
reporting that interventions aimed at reducing stigma might contribute to improve depression 
(Drapalski et al., 2013, Gerlinger et al., 2013, Lysaker et al., 2013, Park et al., 2013). Our study refines 
this perspective by highlighting the role of resilience as a mediator between stigma and depression. 
We found that female gender was associated with higher depression severity. This finding is not 
consistent with some prior reports: more severe depressive symptoms were previously reported in 
male patients (Rocca et al., 2005), and a positive correlation between depression severity and 
positive symptoms was also found in male patients with schizophrenia (Müller, 2007). This 
discrepancy may be due to differences in the samples. However, the NIRP study, for its size and 
design, should have helped in reducing selection bias better than prior investigations. 
 
4.1. Clinical implications 
Clinical strategies targeting resilience could be studied in depth and eventually tested within the 
recovery approach (Hofer et al., 2016; Yoshida et al., 2016). Because of the complex interaction 
between subjective and objective elements of recovery (Jørgensen et al., 2015), strategies aimed at 
improving resilience could ultimately improve recovery (Borras et al., 2009). ‘Personal strength’ 
measures levels of self-efficacy, self-liking, hope, determination and a realistic orientation to life 
(Capanna et al., 2015, Friborg et al., 2003, 2005; Hjemdal et al., 2006). In our study personal strength 
was the item more strongly correlated with the latent construct of resilience, suggesting a high 
relevance of the individual and personal aspect of resilience in buffering depression. Including this 
item in its definition expands resilience's role as a protective factor toward psychiatric symptoms 
(Hjemdal et al., 2006). This psychological approach could be further reshaped into the ‘subjective 
recovery perspective’, as suggested by Hofer et al. (2016). The role of ‘personal resources’ suggests 
that some positive features of adjustment to psychosis may reduce the burden of depression, which, 
in turn, could have a positive impact on the disorder itself. 
The role of positive psychological variables such as resilience and even happiness has not been 
systematically evaluated among people with schizophrenia or other serious mental illnesses (Palmer 
et al., 2014), but the “wellness within illness” issue (Saks, 2013) deserves further exploration. 
 
4.2. Strengths and limitations 
Among the limitations of the study, our model was based on cross-sectional data, which prevent to 
infer causal relationships among variables. Moreover, the explained variance of depression was 
quite low (20.1%), although in line with other studies exploring psychological models of depression 
in schizophrenia (Xu et al., 2013). We are aware that we limited the exploration of personal and 
psychological resources to self-stigma and resilience, while other constructs, such as self-esteem 
and insight, could have a role to predict clinical outcomes and depression (Lysaker et al., 2007, 
Lysaker et al., 2013, Mashiach-Eizenberg et al., 2013, Xu et al., 2013). However the model we report 
could be further enriched in the perspective to include other variables in the causal chain leading to 
depression in schizophrenia. 
The ‘psychological’ nature of depression in schizophrenia seems to offer a wide perspective to 
psychological oriented approaches. Improving ‘personal resources’ could contribute to produce a 
more positive outcome, at least in part of the cases (Vass et al., 2015, Palmer et al., 2014, Yanos et 
al., 2008). 
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